Michael D. Aiona

Michael D. Aiona

Auto-generated profile, based on publicly available information

Michael D. Aiona

Research Center, Shriners Hospitals for Children, Portland, OR 97239, USA

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 December 2017 in Science Translational Medicine
Verified
Journal Article
Open access
PDF file
RCRyan F. Coghlan
Ryan F. Coghlan
JOJon A. Oberdorf
Jon A. Oberdorf
SSSusan Sienko
Susan Sienko
MAMichael D. Aiona
Michael D. Aiona
BBBruce A. Boston
Bruce A. Boston
WHWilliam A. Horton
William A. Horton
A type X collagen fragment derived from endochondral ossification and detected in blood is a marker for growth velocity.

1 July 2009 in Journal of Pediatric Orthopaedics
Verified
Journal Article
Closed access
RHReggie C. Hamdy
Reggie C. Hamdy
KMKathleen Montpetit
Kathleen Montpetit
EREllen M. Raney
Ellen M. Raney
MAMichael D. Aiona
Michael D. Aiona
RFRamona R. Fillman
Ramona R. Fillman
NDNoémi Dahan-Oliel
Noémi Dahan-Oliel
The Ilizarov technique is commonly used for lengthening and deformity corrections of the lower limbs in children. Postoperative pain can be significant, affecting quality of life and functional mobility, and often requiring prolonged medication use. Several studies have investigated the antinociceptive actions of botulinum toxin type A (BtX-A), yet evidence for its use in this population is limited. The objectives were to (1) establish the feasibility of a randomized clinical trial in children undergoing limb lengthening or deformity correction and (2) provide preliminary evidence of the beneficial effects of BtX-A in this population. Fifty-two patients with a mean age of 13.7 years (range, 5 to 21 y) were randomized to receive either BtX-A or an equivalent volume of sterile saline solution (placebo group), as a single dose during the surgical procedure. Pain, medication use, quality of life, and functional mobility outcomes were assessed in all patients. Adverse events were reported for all patients and classified as minor or major. Differences between groups did not reach statistical significance; however, pain at mid-distraction was found to be slightly lower in the BtX-A group, as compared with the placebo group. Patients in the BtX-A group used less parenteral pain medication in the first 4 days after the surgery, had higher quality of life scores at 3 of the 5 time points assessed, and slightly higher functional mobility scores. All adverse events were expected complications of the lengthening process. No event was considered to be a serious adverse event related to the BtX-A injection itself. There was a trend toward fewer major adverse events in the BtX-A group. This pilot study established the feasibility of a randomized controlled trial design for in this population. Its findings indicate that BtX-A injections appear to be safe and effective for reducing pain and improving the quality of life and functional mobility of children undergoing lengthening or deformity corrections of the lower limbs. A larger-scale study is currently underway to confirm these preliminary findings. Level I. Multicenter prospective, randomized, double-blinded, controlled trial.

1 May 1995 in Journal of Pediatric Orthopaedics
Verified
Journal Article
Closed access
JDJ D Dunbar
J D Dunbar
MSM D Sussman
M D Sussman
MAM D Aiona
M D Aiona
Up to 50% of individuals with trichorhinophalangeal syndrome may have Perthes-like hip changes. Thirteen hips in nine skeletally immature patients were studied. Follow-up averaged 4.7 years. The patients were categorized as juvenile (4-8 years) and adolescent (12-14 years) according to their age at presentation. The universal severity of involvement, often older age at presentation, and disproportionate number developing severe deformity with hinge abduction and pain in adolescence distinguished these patients from those with true Perthes' disease. Whether the process can be modified significantly to produce a better outcome is unclear, but management must be directed at avoiding the development of hinge abduction.

1 March 1998 in Anz Journal of Surgery
Verified
Journal Article
Closed access
PDF file
GBGreggory H. Burrow
Greggory H. Burrow
KVKent A. Vincent
Kent A. Vincent
JKJ. Ivan Krajbich
J. Ivan Krajbich
MAMichael D. Aiona
Michael D. Aiona

1 May 2004 in Journal of Pediatric Orthopaedics B
Verified
Journal Article
Closed access
MAMichael D. Aiona
Michael D. Aiona
MSMichael D. Sussman
Michael D. Sussman